Literature DB >> 18475450

Synthesis of a new biological response modifier thyrnosin beta(4) analogue and its restorative effect on depressed.

T Abiko1, H Sekino.   

Abstract

Thymosin beta(4) is a polypeptide isolated from thymosin fraction 5. This peptide exhibits important activities in the regulation and differentiation of thymus-dependent lymphocytes. An analogue of thymosin beta(4), [Phe(4F)(12)] deacetyl- thymosin beta(4), was synthesized by a solution method, followed by deprotection with 1 M trifluoromethanesulphonic acid (TFMSA)-thioanisole (molar ratio, 1:1) in trifluoroacetic acid (TFA) in the presence of dimethlselenium. Finally, the deprotected peptide was incubated with dithiothreitol to reduce sulphoxide on the methionine side chain. The synthetic [Phe(4F)(12)]deacetyl-thymosin beta(4) was found to have a restoring effect on the impaired blastogenic response of T-lymphocytes isolated from uraemic patients with recurrent infectious diseases. This analogue exhibited stronger restorative activity than that of our synthetic deacetyl-thymosin beta(4).

Entities:  

Year:  1992        PMID: 18475450      PMCID: PMC2365328          DOI: 10.1155/S096293519200019X

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  10 in total

1.  A decrease in cell-mediated immunity in uremia associated with an increase in activity of suppressor cells.

Authors:  J Raskova; A B Morrison
Journal:  Am J Pathol       Date:  1976-07       Impact factor: 4.307

2.  Immune system to uremia.

Authors:  H Dobbelstein
Journal:  Nephron       Date:  1976       Impact factor: 2.847

3.  REACTIVITY OF LYMPH NODES IN AZOTEMIC PATIENTS.

Authors:  M M BLACK; A DE CHABON
Journal:  Am J Clin Pathol       Date:  1964-05       Impact factor: 2.493

4.  Synthesis of calf thymosin beta 4 fragment 16-38 and its effect on the impaired blastogenic response of T-lymphocytes of a uremic patient with pneumonia.

Authors:  T Abiko; H Sekino
Journal:  Chem Pharm Bull (Tokyo)       Date:  1987-09       Impact factor: 1.645

5.  Deacetyl-thymosin beta 4: synthesis and effect on the impaired peripheral T-cell subsets in patients with chronic renal failure.

Authors:  T Abiko; H Sekino
Journal:  Chem Pharm Bull (Tokyo)       Date:  1984-11       Impact factor: 1.645

6.  Synthesis of six common amino acid sequence fragments of thymosins beta 4, beta 8 and beta 9 and determination of their effects on the low E-rosette forming cells of lupus nephritis patients.

Authors:  T Abiko; H Sekino
Journal:  Chem Pharm Bull (Tokyo)       Date:  1984-01       Impact factor: 1.645

Review 7.  Immunodeficiency in chronic renal insufficiency.

Authors:  J Traeger; J L Touraine; J Navarro; J Freyria; P Contreras
Journal:  Proc Eur Dial Transplant Assoc       Date:  1980

8.  Inhibitory effect of medium sized molecules from patients with renal failure on lymphocyte stimulation by phytohemagglutinin.

Authors:  J L Touraine; J Navarro; C Corre; J Traeger
Journal:  Biomedicine       Date:  1975-06-10

9.  Synthesis of a thymosin beta 4-like peptide, deacetyl-thymosin beta Xen4, and its restorative effect on depressed lymphocyte blastogenic response to phytohemagglutinin (PHA) in uremic patients.

Authors:  T Abiko; H Sekino
Journal:  Chem Pharm Bull (Tokyo)       Date:  1989-09       Impact factor: 1.645

10.  Complete amino acid sequence of bovine thymosin beta 4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations.

Authors:  T L Low; S K Hu; A L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

  10 in total
  2 in total

Review 1.  The Actin Regulators Involved in the Function and Related Diseases of Lymphocytes.

Authors:  Jianxuan Sun; Xingyu Zhong; Xiaoyu Fu; Heather Miller; Pamela Lee; Bing Yu; Chaohong Liu
Journal:  Front Immunol       Date:  2022-03-16       Impact factor: 7.561

2.  Functional roles of Phe of deacetyl-thymosin beta4 in the impaired blastogenic response of uraemic T-lymphocytes.

Authors:  T Abiko; H Sekino
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.